宏基因组测序市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按产品和服务、技术、按应用、地区和竞争细分

预计宏基因组测序市场在预测期内将出现令人印象深刻的增长。这可以归因于人们对遗传史引起的遗传性疾病的认识不断增强，以及对先进生物信息学工具的需求不断增长。此外，新药和高通量筛选方法的不断发展以及具有成本效益的技术发展预计将在预测期内创造利润丰厚的增长。同样，用于识别新型抗生素和酶的研发活动的增加是推动未来几年市场增长的主要因素。例如，2022年8月，个性化医疗公司OpGen, Inc.宣布在子公司Ares Genetics下推出下一代测序（NGS）服务。

个性化医疗需求不断增长

个性化医疗是全球宏基因组测序市场增长的关键驱动力。个性化医疗旨在根据患者特定的基因组成和环境因素提供针对个体患者的针对性治疗和治疗。宏基因组测序为了解我们体内微生物的组成和功能提供了强大的工具，可用于开发慢性疾病的疗法。宏基因组测序可用于识别患者肠道、皮肤或其他身体部位中存在的特定微生物，并确定这些微生物如何与患者的免疫系统和其他生理系统相互作用。这些信息通常用于开发可以调节患者微生物组的疗法，以治疗癌症、糖尿病和炎症性肠病等疾病。此外，宏基因组测序可用于识别引起传染病的特定病原体，并确定针对这些病原体的最有效治疗方法。这有助于减少广谱抗生素和其他可能导致抗生素耐药性发展的治疗方法的使用。

测序技术的进步

测序技术的进步对全球宏基因组测序市场的增长产生了重大影响。新一代测序和单分子测序技术极大地提高了宏基因组测序的通量、准确性和速度，使其更容易为包括研究人员和临床医生在内的更广泛的用户所使用。这些进步促进了新的生物信息学工具和软件的开发，可以更有效地分析宏基因组测序生成的大量数据。这些工具帮助研究人员和临床医生从宏基因组数据中提取更有意义的见解，并开发新的诊断和治疗应用。此外，便携式测序技术的发展使得宏基因组测序能够在现场进行，从而使研究偏远或资源有限地区的微生物群落成为可能。这为环境监测、公共卫生和农业应用带来了新的机会。随着测序技术的不断进步，宏基因组测序的成本预计将继续下降，从而使世界各地的研究人员和临床医生更容易获得它。随着该技术在一系列研究、临床和商业应用中得到更广泛的采用，预计这将推动全球宏基因组测序市场的增长。

对环境监测和管理的需求不断增加

环境监测和管理是全球宏基因组测序市场增长的重要驱动力。宏基因组测序可用于研究各种环境中的微生物群落，包括土壤、水、空气和建筑环境。这些信息可用于更好地了解这些社区的生态和功能，并製定更有效的环境管理和修復策略。

精准农业需求不断增长

精准农业是全球宏基因组测序市场增长的关键驱动力。精准农业是一种利用数据驱动的方法来优化作物生产并减少对环境影响的农业技术。宏基因组测序可用于研究生活在土壤和植物上的微生物群落，并更好地了解这些群落之间关于植物健康和生长的相互作用。通过研究土壤和植物上的微生物群落，农民可以更好地了解作物的养分和水需求，以及它们对病虫害的易感性。这些信息可用于製定更有针对性的施肥、灌溉和害虫管理策略，从而提高作物产量并减少对环境的影响。

宏基因组测序还可用于研究土壤微生物群落的多样性及其在养分循环、碳固存和土壤团聚等土壤过程中的功能作用。这些信息可用于製定可持续农业的新战略，促进土壤健康和恢復力，同时减少合成肥料和农药的使用。随着精准农业不断受到关注，对宏基因组测序的需求预计将增加，从而推动更适合这些应用的新技术和分析工具的开发。此外，随着农民、研究人员和农业企业采用宏基因组测序来优化作物生产并提高可持续性，预计将推动全球宏基因组测序市场的增长。

基因组学研究资金的可用性不断增加

政府对基因组研究的资助在全球宏基因组测序市场的增长中发挥了关键作用。基因组研究成本高昂，需要在设备、基础设施和人员方面进行大量投资。政府资助可以帮助提供必要的资源来支持宏基因组测序领域的研究和开发。

政府资助支持了新的测序技术、生物信息学工具和数据分析方法的开发，极大地提高了宏基因组测序的准确性和速度。这使得对更大、更复杂的样本进行测序成为可能，从而对各种环境中微生物群落的多样性和功能产生了新的见解。政府资助还支持宏基因组学研究转化为临床和商业应用。例如，政府资助支持开发基于宏基因组学的传染病和癌症诊断测试，以及根据宏基因组学研究获得的见解开发新药和疗法。

除了资助研究和开发之外，政府资助还可以帮助为在研究和临床环境中采用宏基因组测序创造有利的政策环境。这可以包括促进基因组数据在医疗实践和研究中使用的法规，以及促进不同研究小组之间共享基因组数据的倡议。

近期发展

• Oxford Nanopore PromethION：Oxford Nanopore于2018年推出了PromethION测序平台，这是一种便携式、可扩展的系统，用于长DNA片段的实时测序。该平台可用于广泛的应用，包括宏基因组测序。
• QIAGEN Microbial Insights ARB：QIAGEN 于 2020 年推出了 Microbial Insights ARB，这是一款宏基因组分析软件，使研究人员能够研究微生物群落及其在各种环境中的功能。该软件使用带註释的微生物基因组数据库来提供宏基因组数据的准确分类学和功能分析。
• 华大基因一站式微生物组测序服务：2022年，华大基因推出一站式微生物组测序服务，这是利用宏基因组测序分析微生物组样本的综合服务。该服务包括样品製备、测序和数据分析，专为广泛的应用而设计，包括医学和环境研究。
• PacBio Sequel IIe 系统：PacBio 于 2021 年推出了 Sequel IIe 系统，这是一个高通量、长读长的测序平台，单次运行可生成高达 10 TB 的数据。该系统设计用于广泛的应用，包括宏基因组测序。
• Illumina DRAGEN Metagenomics Pipeline：2021年，Illumina推出了DRAGEN Metagenomics Pipeline，这是一种用于分析宏基因组测序数据的软件解决方案。该管道使用先进的算法和机器学习技术来提供微生物群落的准确分类和功能分析。

可用的定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

• 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场细分

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量和验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球宏基因组测序市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按产品和服务（试剂和消耗品、仪器、服务）
  • 按技术（鸟枪法宏基因组测序、16S rRNA 测序、全基因组测序和从头组装、元转录组学）
  • 按应用（药物发现、生态和环境宏基因组学、临床诊断、生物燃料、工业应用）
  • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
  • 按公司划分 (2022)
• 市场地图
  • 按产品和服务
  • 按技术
  • 按应用
  • 按地区

第 6 章：北美宏基因组测序市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按产品和服务（试剂和消耗品、仪器、服务）
  • 按技术（鸟枪法宏基因组测序、16S rRNA 测序、全基因组测序和从头组装、元转录组学）
  • 按应用（药物发现、生态和环境宏基因组学、临床诊断、生物燃料、工业应用）
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲宏基因组测序市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按产品和服务（试剂和消耗品、仪器、服务）
  • 按技术（鸟枪法宏基因组测序、16S rRNA 测序、全基因组测序和从头组装、元转录组学）
  • 按应用（药物发现、生态和环境宏基因组学、临床诊断、生物燃料、工业应用）
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章：亚太地区宏基因组测序市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按产品和服务（试剂和消耗品、仪器、服务）
  • 按技术（鸟枪法宏基因组测序、16S rRNA 测序、全基因组测序和从头组装、元转录组学）
  • 按应用（药物发现、生态和环境宏基因组学、临床诊断、生物燃料、工业应用）
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第 9 章：南美宏基因组测序市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按产品和服务（试剂和消耗品、仪器、服务）
  • 按技术（鸟枪法宏基因组测序、16S rRNA 测序、全基因组测序和从头组装、元转录组学）
  • 按应用（药物发现、生态和环境宏基因组学、临床诊断、生物燃料、工业应用）
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第10章：中东和非洲宏基因组测序市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按产品和服务（试剂和消耗品、仪器、服务）
  • 按技术（鸟枪法宏基因组测序、16S rRNA 测序、全基因组测序和从头组装、元转录组学）
  • 按应用（药物发现、生态和环境宏基因组学、临床诊断、生物燃料、工业应用）
  • 按国家/地区
• MEA：国家分析
  • 南非宏基因组测序
  • 沙特阿拉伯宏基因组测序
  • 阿联酋宏基因组测序

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球宏基因组测序市场：SWOT 分析

第 14 章：波特的五力分析

• 行业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 产品供应
• 最近的发展
• 财务（据报导）
• 主要人员
• SWOT分析
  • BGI Genomics Co Ltd.
  • Eurofins Scientific Se.
  • Illumina Inc.
  • Macrogen Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California Inc.
  • Perkinelmer Inc.
  • Qiagen NV
  • Swift Biosciences Inc.
  • Thermo Fisher Scientific Inc.

第 16 章：战略建议

Metagenomics Sequencing Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing awareness about genetic disorders due to genetic history, along with the growing demand for advanced bioinformatics tools. Also, a growing development of novel drugs and high throughput screening methods along with cost-effective technologies developments are expected to create lucrative growth during the forecast period. Similarly, the rise in research and development activities for identifying newer antibiotics and enzymes is a major factor fueling the growth of the market over the upcoming years. For instance, in August 2022, OpGen, Inc., a personalized medicine company, announced to launch of next-generation sequencing (NGS) services under the subsidiary Ares Genetics.

Growing demand for personalized medicine

Personalized medicine is a key driver for the growth of the Global Metagenomics Sequencing Market. Personalized medicine aims to provide targeted therapies and treatments that are tailored to the individual patient based on their specific genetic makeup and environmental factors. Metagenomics sequencing provides a powerful tool for understanding the composition and function of microbes that are present in our body and can be used to develop therapies for chronic diseases. Metagenomics sequencing can be used to identify the specific microbes present in a patient's gut, skin, or other body sites and determine how these microbes interact with the patient's immune system and other physiological systems. This information is generally used to develop therapies that can modulate the patient's microbiome for treating the conditions such as cancer, diabetes, and inflammatory bowel disease. In addition, metagenomics sequencing can be used to identify the specific pathogens that are causing an infectious disease and to determine the most effective treatments for those pathogens. This can help to reduce the use of broad-spectrum antibiotics and other treatments that can lead to the development of antibiotic resistance.

Advancements in sequencing technologies

Advancements in sequencing technologies have had a significant impact on the growth of the Global Metagenomics Sequencing Market. Next-generation sequencing and single-molecule sequencing technologies have greatly enhanced the throughput, accuracy, and speed of metagenomics sequencing, making it more accessible to a wider range of users, including researchers and clinicians. These advancements have led to the development of new bioinformatics tools and software that can more effectively analyze the vast amounts of data generated by metagenomics sequencing. These tools help researchers and clinicians to extract more meaningful insights from metagenomics data and develop new diagnostic and therapeutic applications. In addition, the development of portable sequencing technologies is enabling metagenomics sequencing to be performed in field settings, making it possible to study microbial communities in remote or resource-limited areas. This is opening new opportunities for environmental monitoring, public health, and agriculture applications. As sequencing technologies continue to advance, the cost of metagenomics sequencing is expected to continue to decline, making it more accessible to researchers and clinicians around the world. This is expected to drive the growth of the global metagenomics sequencing market as the technology becomes more widely adopted in a range of research, clinical, and commercial applications.

Increasing need for environmental monitoring and management

Environmental monitoring and management are important drivers of the growth of the Global Metagenomics Sequencing Market. Metagenomics sequencing can be used to study microbial communities in a wide range of environments, including soil, water, air, and the built environment. This information can be used to better understand the ecology and function of these communities and to develop more effective strategies for environmental management and remediation.

Particularly, metagenomics sequencing can be used to identify and monitor microbial indicators of environmental health, such as pathogenic bacteria, fungi, and viruses. This can be important for identifying and managing outbreaks of infectious diseases in human and animal populations and for monitoring the health of ecosystems and natural resources. In addition, metagenomics sequencing can be used to study the impact of environmental stressors, such as pollution and climate change, on microbial communities and their functions. The growing demand for environmental monitoring and management is driving the development of new metagenomics sequencing technologies and analytical tools that are better suited to these applications.

Rising demand for precision agriculture

Precision agriculture is a key driver for the growth of the global metagenomics sequencing market. Precision agriculture is a farming technique that uses data-driven approaches to optimize crop production and reduce environmental impact. Metagenomics sequencing can be used to study the microbial communities that live in the soil and on plants and to better understand the interactions between these communities about plant health and growth. By studying the microbial communities in the soil and on plants, farmers can gain a better understanding of the nutrient and water requirements of crops, as well as their susceptibility to pests and diseases. This information can be used to develop more targeted fertilization, irrigation, and pest management strategies, leading to increased crop yields and reduced environmental impact.

Metagenomics sequencing can also be used to study the diversity of soil microbial communities and their functional roles in soil processes such as nutrient cycling, carbon sequestration, and soil aggregation. This information can be used to develop new strategies for sustainable agriculture that promote soil health and resilience while also reducing the use of synthetic fertilizers and pesticides. As precision agriculture continues to gain traction, the demand for metagenomics sequencing is expected to increase, driving the development of new technologies and analytical tools that are better suited to these applications. Further, expected to drive the growth of the Global Metagenomics Sequencing Market as farmers, researchers, and agribusinesses adopt metagenomics sequencing to optimize crop production and improve sustainability.

Growing availability of funding for genomics research

Government funding for genomic research has played a critical role in the growth of the Global Metagenomics Sequencing Market. Genomic research is expensive and requires significant investment in equipment, infrastructure, and personnel. Government funding can help to provide the necessary resources to support research and development in the field of metagenomics sequencing.

Government funding has supported the development of new sequencing technologies, bioinformatics tools, and data analysis methods, which have greatly enhanced the accuracy and speed of metagenomics sequencing. This has made it possible to sequence larger and more complex samples, which has led to new insights into the diversity and function of microbial communities in a range of environments. Government funding has also supported the translation of metagenomics research into clinical and commercial applications. For example, government funding has supported the development of metagenomics-based diagnostic tests for infectious diseases and cancer, as well as the development of new drugs and therapies based on insights gained from metagenomics research.

In addition to funding research and development, government funding can help to create a favorable policy environment for the adoption of metagenomics sequencing in research and clinical settings. This can include regulations that promote the use of genomic data in medical practice and research, as well as initiatives that promote the sharing of genomic data across different research groups.

Recent Development

• Oxford Nanopore PromethION: Oxford Nanopore launched the PromethION sequencing platform in 2018, which is a portable and scalable system for real-time sequencing of long DNA fragments. The platform can be used for a wide range of applications, including metagenomics sequencing.
• QIAGEN Microbial Insights ARB: QIAGEN launched the Microbial Insights ARB in 2020, which is a metagenomics analysis software that enables researchers to study microbial communities and their functions in various environments. The software uses a database of annotated microbial genomes to provide accurate taxonomic and functional analysis of metagenomic data.
• BGI One-Stop Microbiome Sequencing Service: In 2022, BGI launched its One-Stop Microbiome Sequencing Service, which is a comprehensive service for analyzing microbiome samples using metagenomics sequencing. The service includes sample preparation, sequencing, and data analysis and is designed for a wide range of applications, including medical and environmental research.
• PacBio Sequel IIe System: PacBio launched the Sequel IIe System in 2021, which is a high-throughput, long-read sequencing platform that can generate up to 10 terabases of data in a single run. The system is designed for a wide range of applications, including metagenomics sequencing.
• Illumina DRAGEN Metagenomics Pipeline: In 2021, Illumina launched its DRAGEN Metagenomics Pipeline, which is a software solution for analyzing metagenomics sequencing data. The pipeline uses advanced algorithms and machine learning techniques to provide accurate taxonomic and functional analysis of microbial communities.

Market Segmentation

Global Metagenomics Sequencing Market can be segmented by product and service, technology, application, and by region. Based on the product and service, the market can be segmented into reagents & consumables, instruments, and services. Based on technology, the market can be segmented into shotgun metagenomic sequencing, 16S rRNA sequencing, whole genome sequencing & de novo assembly, and metatranscriptomics. Based on application, the market can be differentiated into drug discovery, ecological & environmental metagenomics, clinical diagnostics, biofuel, and industrial applications.

Market Players

BGI Genomics Co Ltd., Eurofins Scientific Se., Illumina Inc., Macrogen Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Perkinelmer Inc., Qiagen N.V., Swift Biosciences Inc., Thermo Fisher Scientific Inc. are some of the leading players operating in the Global Metagenomics Sequencing Market.

Report Scope:

In this report, Global Metagenomics Sequencing market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Metagenomics Sequencing Market, By Product and Service:

• Reagents & consumables
• Instruments
• Services

Metagenomics Sequencing Market, By Technology:

• Shotgun metagenomic sequencing
• 16S rRNA sequencing
• Whole genome sequencing & de novo assembly
• Meta transcriptomics

Metagenomics Sequencing Market, By Application:

• Drug discovery
• Ecological & environmental metagenomics
• Clinical diagnostics
• Biofuel
• Industrial applications

Metagenomics Sequencing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Metagenomics Sequencing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Metagenomics Sequencing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
  • 5.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
  • 5.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Product & services
  • 5.3.2 By Technology
  • 5.3.3 By Application
  • 5.3.4 By Region

6. North America Metagenomics Sequencing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
  • 6.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
  • 6.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Metagenomics Sequencing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Services
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Metagenomics Sequencing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Services
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Metagenomics Sequencing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Services
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application

7. Europe Metagenomics Sequencing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
  • 7.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
  • 7.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Metagenomics Sequencing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Services
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Metagenomics Sequencing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Services
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Metagenomics Sequencing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Services
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Metagenomics Sequencing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Services
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Metagenomics Sequencing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Services
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application

8. Asia-Pacific Metagenomics Sequencing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
  • 8.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
  • 8.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Metagenomics Sequencing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Services
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
  • 8.3.2. India Metagenomics Sequencing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Services
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Metagenomics Sequencing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Services
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Metagenomics Sequencing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Services
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Metagenomics Sequencing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Services
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application

9. South America Metagenomics Sequencing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
  • 9.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
  • 9.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Metagenomics Sequencing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Services
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Metagenomics Sequencing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Services
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Metagenomics Sequencing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Services
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application

10. Middle East and Africa Metagenomics Sequencing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
  • 10.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
  • 10.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Metagenomics Sequencing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Services
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Metagenomics Sequencing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Services
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Metagenomics Sequencing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Services
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Metagenomics Sequencing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 BGI Genomics Co Ltd.
  • 15.6.2 Eurofins Scientific Se.
  • 15.6.3 Illumina Inc.
  • 15.6.4 Macrogen Inc.
  • 15.6.5 Oxford Nanopore Technologies Ltd.
  • 15.6.6 Pacific Biosciences of California Inc.
  • 15.6.7 Perkinelmer Inc.
  • 15.6.8 Qiagen N.V.
  • 15.6.9 Swift Biosciences Inc.
  • 15.6.10 Thermo Fisher Scientific Inc.

16. Strategic Recommendations